Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw

Tohoku Journal of Experimental Medicine - Japan
doi 10.1620/tjem.248.27
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Tohoku University Medical Press

Related search

Surgical Therapy for Medication-Related Osteonecrosis of the Jaw in Osteoporotic Patients Treated With Antiresorptive Agents

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2020English

Medication-Related Osteonecrosis of the Jaw

2017English

Higher Incidence of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Castration Resistant Prostate Cancer Treated With Anti-Angiogenic Agents

Cancer Investigation
MedicineCancer ResearchOncology
2009English

Mechanisms of Osteonecrosis of the Jaw in Multiple Myeloma

Современные проблемы науки и образования (Modern Problems of Science and Education)
2015English

Pharmacogenetics of Bisphosphonate-Associated Osteonecrosis of the Jaw

Frontiers in Bioscience - Elite
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2011English

Guidelines for Bisphosphonate-Associated Osteonecrosis of the Jaw

Evidence-Based Dentistry
Dentistry
2008English

Definition of Bisphosphonate-Related Osteonecrosis of the Jaw in 2007

Qeios
2019English

Bisphosphonate-Related Osteonecrosis of the Jaw in Randomized Clinical Trials

Breast Cancer Research and Treatment
Cancer ResearchOncology
2009English

Medication-Related Osteonecrosis of the Jaw: An Overview

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy